SlideShare une entreprise Scribd logo
1  sur  26
Télécharger pour lire hors ligne
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Jeremie M. Gras, M.D. Clinical and Molecular laboratory Cliniques Sud Luxembourg, Arlon, Belgium bioMérieux Satellite Symposium  Eurogin Congress, Monte-Carlo, 18th February 2010
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Plan ,[object Object],[object Object],[object Object],[object Object],[object Object]
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Plan ,[object Object],[object Object],[object Object],[object Object],[object Object]
1.  Background Cervical cancer ,[object Object],[object Object],[object Object],[object Object]
1.  Background HPV mRNA test rationale ,[object Object],[object Object],[object Object],[object Object],1 Schiffman M, Castle PE, Jeronimo J et al.  Lancet 2007 ; 370:890-907. 2 Cattani P, Siddu A, D’Onghia S et al.  J Clin Microbiol 2009 ; 47(7):2136-41.
1.  Background EasyQ® HPV mRNA test  ,[object Object],[object Object],3   Compton J.  Nature 1991 ; 350(6313): 91-2.   Reverse Transcriptase Taq Polymerase Reverse Transcriptase RNAse H T7 polymerase Enzymes + +++ Rapidity Thermal cycles Isothermic (41°C) Conditions RT-PCR NASBA
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Plan ,[object Object],[object Object],[object Object],[object Object],[object Object]
2.  Patients and Methods Lab description ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2.  Patients and Methods ISO 15189 accreditation at Cliniques Sud Luxembourg ,[object Object],[object Object],[object Object]
2.  Patients and Methods Patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2.  Patients and Methods Methods 1. Cytology first performed, then PreservCyt® vial was transmitted to our lab for preparation  (40 mins) 2. Extraction on the easyMAG ®  (40 mins) 3. Incubation  (40 mins) 4. HPV mRNA amplification and detection using the EasyQ ® test ( NASBA )  (120 mins) TAT for 24 samples: 4 hours
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Plan ,[object Object],[object Object],[object Object],[object Object],[object Object]
3.  Results Overall Low rate of invalid results
3.  Results ASCUS ASCUS: 66% have a negative HPV test
3.  Results L-SIL L-SIL: 56% have a negative HPV test
3.  Results H-SIL Negative samples have been retested with a DNA method N.B: HPV 61 and 81 are not HR HPVs
3.  Results Unclear cytology (N=48) 10 active infections with HR HPVs
3.  Results Specificity and NPV ,[object Object],[object Object],[object Object],[object Object]
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Plan ,[object Object],[object Object],[object Object],[object Object],[object Object]
4.  Discussion Study findings (1/2) ,[object Object],[object Object],[object Object],a) Invalid results ,[object Object],[object Object],[object Object],b) Results in ASCUS and L-SIL
4.  Discussion Study findings (2/2) ,[object Object],[object Object],[object Object],c) Interest in patients with unclear cytology results  ,[object Object],[object Object],d) Patients with H-SIL
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Plan ,[object Object],[object Object],[object Object],[object Object],[object Object]
5.  Conclusion ,[object Object],[object Object],[object Object],[object Object]
Thanks Molecular Biology Laboratory,  Cliniques Sud Luxembourg ARLON, Belgium Nicolas Hougardy Head Molecular Lab Pierre Goffinet Lab Director Brigitte Léger Nathalie Pinon Bernadette Legère MLTs Andrée Lemaire Françoise Soblet Maggy Conrardy
Thanks And thank YOU for your attention !
Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Jeremie M. Gras, M.D. Clinical and Molecular laboratory Cliniques Sud Luxembourg, Arlon, Belgium bioMérieux Satellite Symposium  Eurogin Congress, Monte-Carlo, 18th February 2010

Contenu connexe

Tendances

Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...InsideScientific
 
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersMolecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersWAidid
 
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENTAPPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENTDinie Fariz
 
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2QIAGEN
 
Forensic Genetics in the 21st century – meeting the challenges of biological ...
Forensic Genetics in the 21st century – meeting the challenges of biological ...Forensic Genetics in the 21st century – meeting the challenges of biological ...
Forensic Genetics in the 21st century – meeting the challenges of biological ...Thermo Fisher Scientific
 
Invicta eshre-poster-mitochondrial dna
Invicta eshre-poster-mitochondrial dnaInvicta eshre-poster-mitochondrial dna
Invicta eshre-poster-mitochondrial dnaINVICTA GENETICS
 
The Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatmentThe Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatmentPremadarshini Sai
 
Astro annual meeting 2014 highlights
Astro annual meeting 2014 highlightsAstro annual meeting 2014 highlights
Astro annual meeting 2014 highlightsAjeet Gandhi
 
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...QIAGEN
 
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...Candy Smellie
 
BE Retreat 2015 Poster
BE Retreat 2015 PosterBE Retreat 2015 Poster
BE Retreat 2015 PosterEric Ma
 
The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...Candy Smellie
 
Invicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocystInvicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocystINVICTA GENETICS
 
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...QIAGEN
 
MCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapy
MCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapyMCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapy
MCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapyEuropean School of Oncology
 
NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1QIAGEN
 
Stone Studies- World of EndoUrol
Stone Studies- World of EndoUrol Stone Studies- World of EndoUrol
Stone Studies- World of EndoUrol Todd Manning
 

Tendances (20)

Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision ...
 
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Providing ...
 
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersMolecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
 
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENTAPPLICATION OF  NEXT GENERATION SEQUENCING (NGS)  IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
 
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
 
Forensic Genetics in the 21st century – meeting the challenges of biological ...
Forensic Genetics in the 21st century – meeting the challenges of biological ...Forensic Genetics in the 21st century – meeting the challenges of biological ...
Forensic Genetics in the 21st century – meeting the challenges of biological ...
 
Invicta eshre-poster-mitochondrial dna
Invicta eshre-poster-mitochondrial dnaInvicta eshre-poster-mitochondrial dna
Invicta eshre-poster-mitochondrial dna
 
The Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatmentThe Application of Next Generation Sequencing (NGS) in cancer treatment
The Application of Next Generation Sequencing (NGS) in cancer treatment
 
Astro annual meeting 2014 highlights
Astro annual meeting 2014 highlightsAstro annual meeting 2014 highlights
Astro annual meeting 2014 highlights
 
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
 
Next_generation_sequencing_AKT_Nov14
Next_generation_sequencing_AKT_Nov14Next_generation_sequencing_AKT_Nov14
Next_generation_sequencing_AKT_Nov14
 
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
 
BE Retreat 2015 Poster
BE Retreat 2015 PosterBE Retreat 2015 Poster
BE Retreat 2015 Poster
 
The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...The clinical application development and validation of cell free dna assays -...
The clinical application development and validation of cell free dna assays -...
 
Invicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocystInvicta eshre-poster-pregnancy rate after frozen blastocyst
Invicta eshre-poster-pregnancy rate after frozen blastocyst
 
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
 
MCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapy
MCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapyMCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapy
MCO 2011 - Slide 27 - R.A. Stahel - NSCLC systemic therapy
 
NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1
 
Stone Studies- World of EndoUrol
Stone Studies- World of EndoUrol Stone Studies- World of EndoUrol
Stone Studies- World of EndoUrol
 
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testin...
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testin...New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testin...
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testin...
 

En vedette

Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...
Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...
Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...Lifecare Centre
 
Molecular tests to detect human papillomavirus
Molecular tests to detect human papillomavirusMolecular tests to detect human papillomavirus
Molecular tests to detect human papillomavirusTariq Mohammed
 
Comunicacion efectiva cm13151
Comunicacion efectiva cm13151Comunicacion efectiva cm13151
Comunicacion efectiva cm13151Educaciontodos
 
HPV Vaccination Update Grothuesmann
HPV Vaccination Update GrothuesmannHPV Vaccination Update Grothuesmann
HPV Vaccination Update GrothuesmannDr Dirk Grothuesmann
 
Healthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseHealthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseRevital (Tali) Hirsch
 
HPV primary Screening Up to Date2016
HPV primary Screening Up to Date2016HPV primary Screening Up to Date2016
HPV primary Screening Up to Date2016Dr Dirk Grothuesmann
 
Uses of HPV Testing in Triage of cervical Screening
Uses of HPV Testing in Triage of cervical ScreeningUses of HPV Testing in Triage of cervical Screening
Uses of HPV Testing in Triage of cervical ScreeningDr Dirk Grothuesmann
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Clinical Uses of HPV Testing
Clinical Uses of HPV TestingClinical Uses of HPV Testing
Clinical Uses of HPV Testingmacroglobulin35
 
Lab diagnosis of neoplasia
Lab diagnosis of neoplasiaLab diagnosis of neoplasia
Lab diagnosis of neoplasiamadhursejwal
 
HPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: MechanismsHPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: Mechanismsbrandolina1
 
Latest update on cervical cancer & hpv vaccine 2013
Latest update on cervical cancer & hpv vaccine   2013Latest update on cervical cancer & hpv vaccine   2013
Latest update on cervical cancer & hpv vaccine 2013Lifecare Centre
 
Characteristics of benign and malignant neoplasms
Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms
Characteristics of benign and malignant neoplasmsLiezle Joy Gargoles
 
2 pathological diagnosis of cancer
2 pathological diagnosis of cancer2 pathological diagnosis of cancer
2 pathological diagnosis of cancerSumit Prajapati
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virusdrsubir
 
Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancerlok kathayat
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerSubramani Parasuraman
 

En vedette (20)

Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...
Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...
Burden of Cervical Cancer & other HPV Related Diseases : Indian Perspectiv...
 
Molecular tests to detect human papillomavirus
Molecular tests to detect human papillomavirusMolecular tests to detect human papillomavirus
Molecular tests to detect human papillomavirus
 
Comunicacion efectiva cm13151
Comunicacion efectiva cm13151Comunicacion efectiva cm13151
Comunicacion efectiva cm13151
 
What Happens When Women's Preventive Care is Undervalued? Lessons from Romania
What Happens When Women's Preventive Care is Undervalued? Lessons from RomaniaWhat Happens When Women's Preventive Care is Undervalued? Lessons from Romania
What Happens When Women's Preventive Care is Undervalued? Lessons from Romania
 
HPV Vaccination Update Grothuesmann
HPV Vaccination Update GrothuesmannHPV Vaccination Update Grothuesmann
HPV Vaccination Update Grothuesmann
 
Healthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of DiseaseHealthy Savings. Medical Technology and the Economic Burden of Disease
Healthy Savings. Medical Technology and the Economic Burden of Disease
 
HPV primary Screening Up to Date2016
HPV primary Screening Up to Date2016HPV primary Screening Up to Date2016
HPV primary Screening Up to Date2016
 
Uses of HPV Testing in Triage of cervical Screening
Uses of HPV Testing in Triage of cervical ScreeningUses of HPV Testing in Triage of cervical Screening
Uses of HPV Testing in Triage of cervical Screening
 
Hpv vaccination
Hpv vaccination  Hpv vaccination
Hpv vaccination
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Clinical Uses of HPV Testing
Clinical Uses of HPV TestingClinical Uses of HPV Testing
Clinical Uses of HPV Testing
 
Lab diagnosis of neoplasia
Lab diagnosis of neoplasiaLab diagnosis of neoplasia
Lab diagnosis of neoplasia
 
HPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: MechanismsHPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: Mechanisms
 
Latest update on cervical cancer & hpv vaccine 2013
Latest update on cervical cancer & hpv vaccine   2013Latest update on cervical cancer & hpv vaccine   2013
Latest update on cervical cancer & hpv vaccine 2013
 
Characteristics of benign and malignant neoplasms
Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms
Characteristics of benign and malignant neoplasms
 
2 pathological diagnosis of cancer
2 pathological diagnosis of cancer2 pathological diagnosis of cancer
2 pathological diagnosis of cancer
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virus
 
Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancer
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancer
 
Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
 

Similaire à HPV mRNA Test Detects Active Infections in 302 Patients

International Proficiency Study of a Consensus L1 PCR Assay for the Detection...
International Proficiency Study of a Consensus L1 PCR Assay for the Detection...International Proficiency Study of a Consensus L1 PCR Assay for the Detection...
International Proficiency Study of a Consensus L1 PCR Assay for the Detection...Alberto Cuadrado
 
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...Alberto Cuadrado
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany Elshamy
 
Grand rounds 2011 smaller
Grand rounds 2011   smallerGrand rounds 2011   smaller
Grand rounds 2011 smallerKathleen Ellis
 
QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015Kok-Ming Choo
 
QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015Quantum Diagnostics
 
A simple and rapid dna extraction method from FINA nd qPCR
A simple and rapid dna extraction method from FINA nd qPCRA simple and rapid dna extraction method from FINA nd qPCR
A simple and rapid dna extraction method from FINA nd qPCRManish Thakur
 
Role of pcr in diagnostics
Role of pcr in diagnosticsRole of pcr in diagnostics
Role of pcr in diagnosticsTariq Mahmood
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisAbhijit Chaudhury
 
African Swine Fever (ASF) virus genomics and diagnostics
African Swine Fever (ASF) virus genomics and diagnosticsAfrican Swine Fever (ASF) virus genomics and diagnostics
African Swine Fever (ASF) virus genomics and diagnosticsILRI
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...ES-Teck India
 
NIPT inservice talk May 2015
NIPT inservice talk May 2015NIPT inservice talk May 2015
NIPT inservice talk May 2015Kathryn Murray
 
Maldi tof-ms analysis in identification of prostate cancer
Maldi tof-ms analysis in identification of prostate cancerMaldi tof-ms analysis in identification of prostate cancer
Maldi tof-ms analysis in identification of prostate cancerMoustafa Rezk
 
Specimen Handling IOMC.pptx
Specimen Handling IOMC.pptxSpecimen Handling IOMC.pptx
Specimen Handling IOMC.pptxaguseriawan1
 
Nice saint paul. biopsies mammaires, L.Rotenberg 2015
Nice saint paul. biopsies mammaires,  L.Rotenberg 2015Nice saint paul. biopsies mammaires,  L.Rotenberg 2015
Nice saint paul. biopsies mammaires, L.Rotenberg 2015Luc ROTENBERG
 
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...European School of Oncology
 
ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ
ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ
ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ nataliej4
 

Similaire à HPV mRNA Test Detects Active Infections in 302 Patients (20)

International Proficiency Study of a Consensus L1 PCR Assay for the Detection...
International Proficiency Study of a Consensus L1 PCR Assay for the Detection...International Proficiency Study of a Consensus L1 PCR Assay for the Detection...
International Proficiency Study of a Consensus L1 PCR Assay for the Detection...
 
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Product...
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide results
 
Grand rounds 2011 smaller
Grand rounds 2011   smallerGrand rounds 2011   smaller
Grand rounds 2011 smaller
 
Seminario molecular
Seminario molecularSeminario molecular
Seminario molecular
 
Seminario molecular
Seminario molecularSeminario molecular
Seminario molecular
 
QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015
 
QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015
 
A simple and rapid dna extraction method from FINA nd qPCR
A simple and rapid dna extraction method from FINA nd qPCRA simple and rapid dna extraction method from FINA nd qPCR
A simple and rapid dna extraction method from FINA nd qPCR
 
Role of pcr in diagnostics
Role of pcr in diagnosticsRole of pcr in diagnostics
Role of pcr in diagnostics
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosis
 
African Swine Fever (ASF) virus genomics and diagnostics
African Swine Fever (ASF) virus genomics and diagnosticsAfrican Swine Fever (ASF) virus genomics and diagnostics
African Swine Fever (ASF) virus genomics and diagnostics
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
 
NIPT inservice talk May 2015
NIPT inservice talk May 2015NIPT inservice talk May 2015
NIPT inservice talk May 2015
 
Tuberculosis diagnostics
Tuberculosis diagnosticsTuberculosis diagnostics
Tuberculosis diagnostics
 
Maldi tof-ms analysis in identification of prostate cancer
Maldi tof-ms analysis in identification of prostate cancerMaldi tof-ms analysis in identification of prostate cancer
Maldi tof-ms analysis in identification of prostate cancer
 
Specimen Handling IOMC.pptx
Specimen Handling IOMC.pptxSpecimen Handling IOMC.pptx
Specimen Handling IOMC.pptx
 
Nice saint paul. biopsies mammaires, L.Rotenberg 2015
Nice saint paul. biopsies mammaires,  L.Rotenberg 2015Nice saint paul. biopsies mammaires,  L.Rotenberg 2015
Nice saint paul. biopsies mammaires, L.Rotenberg 2015
 
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
 
ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ
ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ
ỨNG DỤNG CHẨN ĐOÁN PHÂN TỬ TRONG NHÓM BỆNH UNG THƯ
 

HPV mRNA Test Detects Active Infections in 302 Patients

  • 1. Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Jeremie M. Gras, M.D. Clinical and Molecular laboratory Cliniques Sud Luxembourg, Arlon, Belgium bioMérieux Satellite Symposium Eurogin Congress, Monte-Carlo, 18th February 2010
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. 2. Patients and Methods Methods 1. Cytology first performed, then PreservCyt® vial was transmitted to our lab for preparation (40 mins) 2. Extraction on the easyMAG ® (40 mins) 3. Incubation (40 mins) 4. HPV mRNA amplification and detection using the EasyQ ® test ( NASBA ) (120 mins) TAT for 24 samples: 4 hours
  • 12.
  • 13. 3. Results Overall Low rate of invalid results
  • 14. 3. Results ASCUS ASCUS: 66% have a negative HPV test
  • 15. 3. Results L-SIL L-SIL: 56% have a negative HPV test
  • 16. 3. Results H-SIL Negative samples have been retested with a DNA method N.B: HPV 61 and 81 are not HR HPVs
  • 17. 3. Results Unclear cytology (N=48) 10 active infections with HR HPVs
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24. Thanks Molecular Biology Laboratory, Cliniques Sud Luxembourg ARLON, Belgium Nicolas Hougardy Head Molecular Lab Pierre Goffinet Lab Director Brigitte Léger Nathalie Pinon Bernadette Legère MLTs Andrée Lemaire Françoise Soblet Maggy Conrardy
  • 25. Thanks And thank YOU for your attention !
  • 26. Molecular diagnostics of HPV infection using E6 and E7 mRNA detection: experience in 302 patients Jeremie M. Gras, M.D. Clinical and Molecular laboratory Cliniques Sud Luxembourg, Arlon, Belgium bioMérieux Satellite Symposium Eurogin Congress, Monte-Carlo, 18th February 2010